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Parachlamydiaceae
as Rare Agents of
Pneumonia 
To the Editor: Members of the
Parachlamydiaceae family are emer-
ging intracellular bacteria living in
amoebae (1,2). Serologic studies have
suggested that Parachlamydia acan-
thamoeba might be an agent of com-
munity-acquired pneumonia transmit-
ted from a water source (3,4). In a sin-
gle occasion, 16s rRNA of a member
of the Parachlamydiaceae family was
amplified and sequenced from a bron-
choalveolar lavage sample (5). Thus,
to specify the role played by the
Parachlamydiaceae as agents of
lower respiratory tract infection, we
developed a real-time polymerase
chain reaction (PCR) assay and
applied it to 1,200 bronchoalveolar
lavage samples, taken mainly from
patients with pneumonia of unknown
cause and received in our diagnostic
microbiology laboratory between
1997 and 2002. 
DNA extraction was performed by
using the MagNAPure LC instrument
and the MagNA Pure LC DNA
Isolation Kit III (Roche Molecular
Biochemicals, Mannheim, Germany).
Real-time PCR was performed by
using TaqMan technology and target-
ing the gene encoding for a nonmito-
chondrial ATP/ADP translocase
(GenBank accession no. AF490592).
This energy parasite gene is present
only in rickettsiae, chlamydiae, and
plant plastids (6). The master mixture
was prepared from the TaqMan
Universal Master Mix kit (Applied
Biosystems, Foster City, CA), accord-
ing to the manufacturer’s instructions,
and included 200 nM of each primer
(Adp81F 5´- TAGTGATCTGC-
TACGGGATTT, Adp84R 5´-TTG-
GATTAGGATATTGCAATTT) and
200 nM of the fluorescent labeled
probe (6-FAM-5´-AACCTTGTA-
GAAGTAACCTGGAA-
GAACCAGC-3´-TAMRA, where 6-
FAM is 6-carboxyfluorescein and
TAMRA is 6-carboxytetramethylrho-
damine). Amplification was carried
out on the ABI 7700 sequence detec-
tion system (TaqMan system, Applied
Biosystems), by running 45 cycles,
with annealing temperature of 52°C
and polymerization temperature of
60°C. To prevent carryover, 200 µ M
of uracil triphosphate was part of the
master mixture, and uracil-N-glycosy-
lase was used systematically. Para-
chlamydia acanthamoeba strain Hall
coccus (kindly provided by T.J.
Rowbotham) (3) and sterile water
were used as positive and negative
controls, respectively. In addition,
PCR was tested on Chlamydophila
pneumoniae and  Chlamydia psitacci
and four strains of Rickettsia. All but
one (Rickettsia montana) was nega-
tive, as were 64 sterile water controls. 
Of the 1,200 bronchoalveolar
lavage samples tested, 5 (0.42%) were
positive. When PCR was repeated for
those five samples, four were negative
for P. acanthamoeba DNA, and only
one was a true positive, confirmed by
sequencing the product of the addi-
tional PCR. The sequence shared
100% DNA homology with P. acan-
thamoeba strain Hall coccus
(GenBank accession no. AF490592).
The patient, a 31-year-old man who
was HIV-positive, had pneumonia,
cough, and no fever. Chest x-ray
examination showed an opacity in the
right lung and a bilateral infiltrate.
Leukocyte count was 5,000/mm3 with
80 CD4 cells/mm3; microbiologic
investigations (in which the bron-
choalveolar lavage was examined for
cytomegalovirus,  Chlamydophila
pneumoniae,  Legionella pneumo-
phila,  Pneumocystis carinii,  myco-
bacteria, and Toxoplasma gondii) did
not identify a causal agent. 
We developed a highly sensitive
PCR, which could amplify as few as
10 bacteria. The assay results in a rel-
atively high specificity (1,195/ 1,199;
99.67%) because it uses a target gene
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Chlamydiae, and plant plastids, and
uses a specific DNA probe. We con-
siderably decreased the risk of hori-
zontal and vertical contamination of
the PCR reaction by using uracil and
uracil-N-glycosylase and by keeping
reaction cups closed since the first
amplification cycle.
More importantly, our study
showed that Parachlamydia DNA is
rarely found in bronchoalveolar
lavage samples (0.083%). This sug-
gests that persons are infrequently
exposed to Parachlamydia organisms
and, consequently, members of the
Parachlamydiaceae seldom cause
pneumonia in humans. In the only
positive sample, whether Para-
chlamydia originated from bacteria in
the oropharynx, from water, or from a
colonization of the lower respiratory
tract was not known; whether they
caused the patient’s pneumonia is also
not known. That two strains of
Parachlamydia found in amoebae
were recovered from the nasopharynx
of healthy volunteers (7) favors the
first hypothesis. However, that the
positive broncholaveolar lavage spec-
imen was taken from an HIV-positive
patient with community-acquired
pneumonia suggests that Parachla-
mydia might occasionally play a path-
ogenic role in AIDS patients.
Moreover, any amoebae-associated
bacteria should be considered as a
potential emerging pathogen because
intra-amoebal growth may lead to the
selection of virulence traits and to the
adaptation to professional phago-
cytes, such as alveolar macrophages
(1,2). Further studies are warranted to
determine whether Parachlamy-
diaceae causes community-acquired
pneumonia, particularly in HIV-
infected persons.
Acknowledgments
We thank the Swiss National Science
Foundation for funding the postodoctoral
fellowship of Gilbert Greub in the Unité
des Rickettsies, Marseille, France, and
Olivier Castigliola for technical assis-
tance.
Gilbert Greub,* Pierre Berger,*
Laurent Papazian,† 
and Didier Raoult* 
*Université de la Méditerranée, Marseille,
France; and †Hôpital Sainte Marguerite,
Marseille, France 
References
1. Greub G, Raoult D. Parachlamydiaceae,
potential emerging pathogens. Emerg Infect
Dis 2002;8:625–30.
2. Greub G, Raoult D. Crescent bodies of
Parachlamydia acanthamoeba and its life
cycle within Acanthamoeba polyphaga: an
electron micrograph study. Appl Environ
Microbiol 2002;68:3076–84.
3. Birtles RJ, Rowbotham TJ, Storey C,
Marrie TJ, Raoult D. Chlamydia-like obli-
gate parasite of free-living amoebae. Lancet
1997;349:925–6.
4. Marrie TJ, Raoult D, La Scola B, Birtles
RJ, de Carolis E. Legionella-like and other
amoebal pathogens as agents of communi-
ty-acquired pneumonia. Emerg Infect Dis
2001;7:1026–9.
5. Corsaro D, Venditti D, Le Faou A,
Guglielmetti P, Valassina M. A new
chlamydia-like 16s rDNA sequence from a
clinical sample. Microbiology 2001;
147:515–6.
6. Wolf YI, Aravind L, Koonin EV.
Rickettsiae and  chlamydiae evidence of
horizontal gene tranfer and gene exchange.
Trends Genet 1999;15:173–5.
7. Amann R, Springer N, Schonhuber W,
Ludwig W, Schmid EN, Muller KD, et al.
Obligate intracellular bacterial parasites of
Acanthamoebae related to Chlamydia spp.
Appl Environ Microbiol 1997;63:115–21.
Address for correspondence: Didier Raoult,
Unité des Rickettsies, CNRS UPRESA 6020
Faculté de Médecine, Université de la
Méditerranée, 27 Boulevard Jean Moulin,
13385 Marseille Cedex 05, France; fax: 00-33-
491-83-03-90; email: didier.raoult@medecine.
univ-mrs.fr
Hantaviruses in the
Czech Republic
To the Editor: Infections caused
by hantaviruses have been known for
a long time, but their causative agent
was not detected until 1976 (1). These
viruses of the genus Hantavirus, fam-
ily  Bunyaviridae, have >20 geno-
types. Hantaviruses circulate in wild
rodents within natural foci over
Euroasia and North and South
America. They cause asymptomatic
persistent infections in these small
mammals. Humans may acquire
infection accidentally from inhalation
of virus-contaminated aerosols of
rodent excreta. Hantavirus genotypes
may be nonpathogenic for humans or
cause serious diseases with high death
rates. In Eurasia, these pathogens
involve primarily the kidney and
cause hemorrhagic fever with renal
syndrome; in North and South
America, these pathogens involve pri-
marily the lung and cause hantavirus
cardiopulmonary syndrome.
First reports on the occurrence of
hantaviruses in central Europe origi-
nated from former Czechoslovakia
(2,3) and Germany (4) and date back
to 1984 and 1985, respectively. The
first cases of hantavirus disease in
humans in the Czech Republic were
reported in 1992 (5). This flulike dis-
ease accompanied by microhematuria
was recorded in southern Moravia.
Another severe imported case was
described in a soldier on active mili-
tary duty in the Balkans (6). The first
isolation of nonpathogenic hantavirus
Tula was reported in the Czech
Republic (7). Currently, several han-
tavirus infections have been recorded
in humans, manifesting mainly as
interstitial nephritis. One fatal case
was also reported in a patient who had
never travelled outside the Czech
Republic.
We conducted studies of hantavirus
ecology in the Czech Republic and
hantavirus seroprevalence in the Czech
population. As in neighboring Slovakia
(8), hantaviruses of three genotypes,
i.e., Dobrava, Puumala, and Tula, were
identified in the Czech Republic. Most
serious infections are caused by the
Dobrava genotype; Tula genotype